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Abstract 
Background: Accurate HIV testing in pregnancy is critical to the prevention of mother to child transmission of HIV 
infection and linkages to other preventive strategies.
Aims and objectives: This study determined the sensitivity, specificity negative and positive predictive value of serial 
rapid testing of HIV among pregnant women in Nnewi, south east Nigeria.
Methodology: This was a comparative descriptive study conducted over a 4-month period. Serial rapid testing algo-
rithm was compared with conventional ELISA testing after obtaining informed consents from the pregnant women. 
All positive and discordant results were confirmed with western blot HIV test. Participants also completed a question-
naire. Data analysis was done using SPSS version 20.
Result: A total of 166 pregnant women participated in this study. The mean age of the participants was 
29 ± 4.3 years. The HIV prevalence was highest in the 25–29 years category. This was also the modal age category. 
Majority of the women were multiparous. The prevalence of HIV infection was 12 %. The sensitivity, specificity, nega-
tive and positive predictive value of serial rapid HIV testing was 95, 100, 99.3 and 100 % respectively.
Conclusion: The sensitivity of the serial rapid test algorithm was high but still lower than the WHO recommended 
99 % and above. The 100 % specificity and positive predictive value makes it a good diagnostic test strategy. There is 
need for regular review of HIV test kits and policy.
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Background
It has been estimated that sub-Sahara Africa contributes 
22.4 million of the 32.4 million cases of HIV infection 
worldwide [1]. This represents 67  % of HIV infection. 
More worrisome is the fact that HIV in this region is 
wearing a woman’s face with 61  % of HIV infections in 
this region occurring in women [1]. This has a detrimen-
tal implication for mother to child transmission of HIV 
infection. Overall, it has been estimated that 60 million 
people have been infected with HIV since the beginning 
of the epidemic and 25 million people have died of HIV-
related causes [2].
Nigeria’s HIV infection is peculiar because of the coun-
try’s population. It has been estimated that Nigeria has 
one of the highest number of people living with HIV 
infection [3]. The annual HIV exposed births in Nigeria 
in 2009 was 56,681 [4]. More than 90  % of paediatrics 
HIV infections are as a result of mother to child trans-
mission [5]. Diagnosis is also more challenging because 
of presence of HIV-2 in the region.
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HIV prevention and treatment hinges on the avail-
ability of accurate and feasible diagnostic tests. HIV 
counseling and testing is the gateway for HIV preven-
tion, care, treatment and support of interventions. 
Among pregnant women, screening has proven to be 
more effective than risk-based approach for detect-
ing unsuspecting maternal HIV infection [6]. Screen-
ing for HIV infections were previously done using 
conventional ELISA and confirmed with western blot 
testing until the evolution rapid HIV testing kits. 
Both parallel and serial rapid test algorithm has been 
used for screening and diagnosis of HIV infection in 
Nigeria.
The routine use of conventional ELISA was abandoned 
because it is technically demanding, and requires sophis-
ticated, regularly maintained equipment and constant 
supply of electricity. The ELISA kits use both natural and 
recombinant antigens. They are updated continuously to 
increase their sensitivity to newly discovered species like 
group O viruses [7]. The fourth generation ELISA also 
detects the presence of p24 antigen thereby improving 
the sensitivity.
Rapid tests for the detection of antibodies to HIV 
have revolutionized the diagnosis and management of 
patients with HIV infection. It allows timely point of 
care, provision of results and do not require the labo-
ratory facilities needed for conventional ELISA and 
western blot testing [8–11]. Rapid HIV tests have been 
widely used for voluntary HIV counseling and test-
ing, antenatal surveillance, and population screening 
[10, 11]. These tests are simple to use and cheaper than 
laboratory based HIV antibody tests [12]. Introduction 
of rapid HIV tests has contributed in the scaling up of 
HIV-testing programme and enabled diagnosis of HIV 
in persons who might not have had their infections 
diagnosed otherwise [13–17]. This is more pertinent in 
sub-Sahara Africa with very high disease burden and 
weak health sector.
The sensitivity of many rapid test kits is comparable to 
the conventional enzyme immunoassays [15–18]. Eller 
et  al. reported a sensitivity of 98.6  % and specificity of 
99 % in Uganda [16]. This agrees with the result of several 
studies [18–20]. These results met the WHO criteria of 
98 % sensitivity and 99 % specificity. Rapid HIV tests have 
been developed for on-site real time testing and quality 
of testing is dependent on user and test kits. High false 
positive rates have been observed with some test kits 
[21–25].
Studies have reported poor positive predictive value of 
three rapid tests if weak bands are interpreted as positive 
according to manufacturers’ recommendation [23, 26]. It 
has been postulated that weak positive bands may reflect 
cross-reactions with other infections [23].
Various HIV testing algorithms were introduced to 
improve the accuracy of testing. These testing algorithms 
involve a combination of tests used either in sequence or 
parallel, designed to achieve predictive values close to 
100 %. These include the parallel testing and serial test-
ing. Parallel screening is the use of two tests simultane-
ously, each test being a check on the other, and can be 
considered to create efficiency. Serial testing involve the 
use of rapid test kit with sensitivity close to 100 %. Second 
test is done only if the initial test is positive. The parallel 
approach is expensive and in lower prevalence settings, 
may lead to the use of longer numbers of tests than the 
use of a serial strategy. Currently serial rapid testing is the 
option in Nigeria based WHO recommendation.
Despite the improvement to access and wide scale 
implementation, quality assurance mechanism is very 
important to validate the accuracy as stated by the man-
ufacturers. In addition, it will also detect post market 
problems like batch variations, storage problems and fake 
products.
High false positive rates have an adverse effect on the 
health system and individuals. The individuals will suf-
fer stigma and discrimination, with attendant psycho-
logical and social consequences. She may also be prone 
to domestic violence and exposed to the unnecessary 
and potentially toxic medical treatment. This will lead 
to increase in antiretroviral drugs budget and will put a 
heavy strain on the health sector especially in develop-
ing countries. In addition, a HIV negative person will be 
meant to live with the stigma associated with the disease 
with attendant psychological and social consequences. 
False negative results have a great implication for mother 
to child transmission of HIV infection. These women are 
denied the benefit of antiretroviral therapy in reduction 
of mother to child transmission.
Studies have shown reduced ability of rapid test kits in 
detecting some strains of HIV-1 and HIV-2 antibodies 
when compared with conventional ELISA [26–29]. More 
worrisome is the observation that some rapid test kits 
used in different algorithm detect the same type of anti-
gens contrary to WHO recommendations [30].
Rapid point of care HIV tests has created new chal-
lenges and opportunities for service providers, policy 
makers and researchers concerning broad scale identi-
fication of HIV seropositive persons. The major chal-
lenge is to identify most suitable assays for a given 
circumstance without compromising the test results. It is 
essential to establish quality assurance programs so that 
benefits of rapid point of care HIV test will be optimized. 
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This will help to detect batch to batch differences, stor-
age and other post market problems that may hinder the 
accuracy of the test kits.
Periodic evaluations of these kits will help in mak-
ing sure that the kits meet the minimum standard. This 
study evaluated the accuracy of the serial rapid test algo-
rithm by determining the sensitivity, specificity, negative 
and positive predictive values of the serial rapid HIV test 
algorithm among booked antenatal women in Nnewi, 
South East Nigeria, which is one of the centres of excel-
lence for prevention of mother to child transmission of 
HIV infection in Nigeria.
Subjects, materials and methods
Study design
This was a descriptive comparative study conducted 
among pregnant women. The sensitivity, specificity, 
negative and positive predictive value of rapid HIV 
kits (Determine and UNi-Gold) using the serial test-
ing algorithm was determined. We used conventional 
ELISA as the gold standard for screening and West-
ern blot as the Gold standard for confirmation of all 
positive and discordant results. A total of 166 preg-
nant women participated in this study. This study was 
approved by the ethics committee of Nnamdi Azikiwe 
University Teaching Hospital, Nnewi, Anambra state, 
Nigeria.
Study area
The study was conducted at Nnamdi Azikiwe Univer-
sity Teaching Hospital (NAUTH) Nnewi, between Janu-
ary 2012 and April 2012. NAUTH is one of the pioneer 
PMTCT referral centre of excellence in Nigeria.
Study population
This comprised of pregnant women attending antenatal 
clinic in NAUTH, Nnewi within the study period.
Inclusion criteria
1. Pregnant women presenting at antenatal clinic in 
NAUTH.
2. Pregnant women that gave informed consent.
Exclusion criteria
1. Non pregnant women
2. Pregnant women previously confirmed HIV seropos-
itive.
3. All pregnant women that withheld consent for the 
study.
Measure of outcome
The main outcome measure was determination of sensi-
tivity, specificity, negative and positive predictive value of 
serial rapid test algorithm using Determine-1/2 and Uni-
Gold rapid test kits.
Laboratory procedures
Pre-test counseling was carried out after comple-
tion of the questionnaire. The researcher or any of the 
research assistant performed a venipuncture to col-
lect 5  ml of blood. Part of the blood sample was emp-
tied into an EDTA bottle that was appropriately coded 
to match the subject’s questionnaire for easy identifi-
cation. This was centrifuged and the serum stored for 
conventional ELISA batch testing (Bio Rad, France) and 
western blot testing (NEW LAV BLOT 1 by Bio Rad, 
France) where applicable. The samples for western blot 
were analysed at the central public laboratory Yaba, 
Lagos. The remaining sample was handed to Institute 
of human virology of Nigeria (IHVN) scientist for HIV 
screening using Determine HIV-1/2®(Alere Japan) and 
UniGold HIV rapid test kits (Trinity Biotech Ireland) 
where applicable. The first test was done using Deter-
mine HIV rapid test kit. Those that tested negative were 
declared negative. Those that tested positive for the 
first test were retested using Unigold HIV rapid test kit. 
Concordant or discordant positive samples were sent 
for confirmatory test with western blot. These women 
were told that further test will be done to confirm the 
result. They were given immediate appointment in the 
antenatal clinic. The subject that had false result was 
contacted through the antenatal clinic. She was enrolled 
into the PMTCT programme after counseling. All the 
clients, regardless of the result received routine coun-
seling on risk reduction practices. The folder was tagged 
to avoid double recruitment of the subject. The manu-
facturer’s instructions were strictly adhered to in per-
forming the tests. The rapid tests and ELISA test were 
done at Nnamdi Azikiwe University Teaching Hospital 
Nnewi while the western blot test was carried out at the 
central public health laboratory in Yaba, Lagos, Nigeria 
using NEW LAV BLOT 1 (BIO RAD France). The cold 
chain was maintained in transporting the samples from 
Nnewi to Lagos.
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The flow chart is shown in the table below 
SRT serial rapid test algorithm, EIA conventional 
ELISA, WB western blot.
Disclosure of result
The client was given a negative result in an individual-
ized posttest counseling session. The confirmed posi-
tive results were disclosed in an individualized posttest 
counseling session in the follow up appointment. The dis-
cussion on the disclosure of the result was made as well 
as partner and family testing. The patient was enrolled 
in the hospital PMTCT services and social support ser-
vices. False negative result was defined as a sample that 
gave a negative result with the first rapid test and classi-
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was confirmed positive with western blot. False positive 
result was defined as a sample that gave a positive test 
result with two independent rapid tests, and classified 
as positive according to the WHO two-test algorithm, 
which was not confirmed by western blot testing.
Statistical analysis
Statistical analysis of the result was done using SPSS ver-
sion 20.0. The level of statistical significance was set at p 
value 0.05 providing 95 % confidence interval.
Limitations of the study
The constraint of financial resources limited the sam-
ple size because the researchers bore all the expenses 
incurred in the course of the study.
Ethical consideration
Written informed consent was obtained from the sub-
jects that participated in the study and the study was per-
formed in accordance with the Declaration of Helsinki. 
Ethical clearance was by the ethics committee of Nnamdi 
Azikiwe University Teaching Hospital, Nnewi, Anambra 
state Nigeria before the commencement of the study.
Results
One hundred and sixty-six pregnant women participated in 
this study. The mean age of the women was 29 years ± 4.3. 
Majority of the women were in the age category of 
25–29 years 9(47.4 %). Two were below 20 years while only 
one was above 40 years. Only one woman was 40 years.
A greater percentage (96.4  %) was currently married. 
Two women each (1.2 %) were single, divorced or widowed 
respectively. Twenty women were confirmed HIV positive 
with western blot giving a prevalence of 12.04 %. None of 
the positive women was below 20 years. The highest HIV 
prevalence was documented in the 25–29 age category.
The evaluation of the serial rapid test algorithm showed 
that 19 patients tested positive. There was one false nega-
tive but no false positive (sensitivity of 95 % and specificity 
of 100  %). Twenty-seven tested positive to the conven-
tional ELISA test and western blot confirmed only 20 of 
the women positive for HIV. There were 7 false positive 
and no false negative (sensitivity of 100 % and specificity 
of 95.3 %) for the conventional ELISA. Table 1 shows the 
distribution of disease state and age group while Table 2 
shows rapid test and ELISA test concordance.
Sensitivity of the serial rapid test was 95  % while the 
specificity was 100  %. The positive predictive value was 
100 %. The evaluation of serial rapid HIV and ELISA test 
results are shown in Table 3. Table 4 shows Rapid Test, 
ElISA and Western blot concordance.
Discussion
The mean age of the women in this study was 29  years   
± 4.3 and the modal age category was 25–29 years. This 
age category also has the highest number of infected 
Table 1 Age and confirmed result
Age range Negative N % Positive N  % Total N  %
<20 2 1.2 0 0.0 2 1.2
20–24 19 11.4 2 2.4 21 12.7
25–29 55 33.1 9 5.4 64 38.6
30–34 50 30.1 6 3.6 56 33.7
35–39 20 12.0 2 1.2 22 13.2
≥40 0 0.0 1 0.6 1 0.6
Total 146 88 20 12.0 166 100
Table 2 Rapid HIV and ELISA concordance
Concordance Frequency Percentage
Negative concordance 139 83.7
Positive concordance 19 11.5
RAPID test positive, ELISA negative 0 0
RAPID test negative, ELISA positive 8 4.8
Table 3 Accuracy of serial rapid test algorithm
Sensitivity = 95 %, specificity = 100 %, negative predictive value = 99.3 %, 
positive predictive value = 100 %
Test result Disease present Disease absent Total
Positive 19 0 19
Negative 1 146 147
Total 20 146 166
Table 4 Rapid test, ELISA and western blot concordance
SRTA serial rapid test algorithm, EIA conventional ELISA, WB western blot
Cohort Number
SRTA positive, EIA positive, WB positive 19
SRTA negative, EIA positive, WB Positive 1
SRTA negative, EIA positive WB negative 7
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women. This finding agrees with the highest age specific 
prevalence of HIV infection among women in a national 
survey in Nigeria [31]. This has a great implication on 
mother to child transmission of HIV infection. This is 
because these women are at the peak of their reproduc-
tive life. It may also affect the overall HIV prevalence rate 
bearing in mind the high fertility rate in Nigeria and the 
total population of the country. The prevalence of HIV 
infection among pregnant women in this study was 12 %. 
This is high but comparable figure 10.5 % recorded in a 
previous in Nnewi [32]. The high prevalence rate may be 
because the hospital is a referral centre for the manage-
ment of HIV positive patients in the region.
In this study, the sensitivity of serial rapid test algo-
rithm was 95  %. This is high but lower than the WHO 
recommended sensitivity of rapid test of ≥99  % [33]. 
Most of the published works on accuracy of rapid test 
in HIV diagnosis in Nigeria evaluated each kit sepa-
rately. Nkwocha recorded a lower sensitivity of 86.6  % 
for Determine rapid kits which is lower than the observa-
tion in our study [34]. The difference may be due to the 
use of a serial rapid test algorithm in our study. Using an 
established algorithm as recommended by WHO in the 
screening of HIV improves the accuracy of the study (i.e. 
the sensitivity, specificity, positive predictive value and 
negative predictive value).
The specificity and positive predictive value of serial 
rapid test algorithm in this study was 100 %. Several stud-
ies have recorded specificity and positive predictive value 
of 98  % and above which meets the WHO recommen-
dation [16–18]. This is good news considering the fact 
that in low resource countries, rapid HIV kits are used 
for both screening and confirmation of diagnosis. Well-
established algorithms have contributed immensely to 
the scaling up of HIV testing, diagnosis, prevention and 
treatment.
A case of false negative result recorded in this study 
underscores the potential for false result when using 
rapid test algorithm for screening and diagnosis of HIV 
infection in pregnant women. Some studies have also 
observed false results with HIV test algorithm which 
underscores the need for periodic evaluation of differ-
ent HIV testing strategies [35–37]. Klarkowski et al. in 
a multicenter and multi country study observed varia-
tions in accuracy of testing between regions and centres 
in Ethopia and Myanner [37]. Bavewo et  al. also noted 
high false positive result with serial rapid HIV test algo-
rithm [38].
Our study did not evaluate different points of flaws 
in testing. Another multicenter study that will include 
primary, secondary and tertiary health centres will be 
needed to determine the various points of flaws in the 
testing. These will help to maintain the accuracy of test-
ing and good quality assurance.
The high rate of false positive result recorded with con-
ventional ELISA calls for further study. Causes of false 
positive results include cross reactivity or non-specific 
reactivity. Some authors have also propounded that 
the false positive results may be due to some strains of 
HIV-2 and HIV-1 group O whose antigens are not eas-
ily detected [35, 36]. Further studies will be required to 
prove or refute this submission.
This study confirms the known fact that rapid HIV 
testing offers an enormous opportunity for HIV screen-
ing and diagnosis and linkages to other HIV services 
aimed at reducing the HIV/AIDS scourge. It is more per-
tinent in developing countries where it can be used for 
screening and diagnosis. However, there is need for local 
and national quality assurance program to make sure 
that high standards are always maintained. This can be 
achieved by periodic evaluation of rapid HIV test kits and 
different test algorithm. Institution-based and national 
periodic evaluation is very important in maintaining high 
accuracy of testing.
Conclusion
Despite the high accuracy of serial rapid test algorithm, 
there is still room for improvement of testing because of 
the potential for false results as recorded in this study and 
other studies. There should be a mechanism for periodic 
evaluation at various levels of testing ranging from pri-
mary, secondary and tertiary health institutions. This will 
help to ascertain point of testing accuracy and identify 
some of the flaws associated with testing. We also pro-
pose that conventional ELISA test may be used in tertiary 
centres as part of the testing strategies to reduce false 
negative results. There is need for sustained funding of 
research in this area by international, regional and local 
institutions. Retesting of pregnant women in labour will 
also help to improve dictation rate and better patients’ 
management.
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